{
  "id": 15637935,
  "title": "Kane to Showcase revyve® at Wounds Canada National Hybrid Conference",
  "url": "https://urgent.news/2026/10/19/kane-to-showcase-revyve-at-wounds-canada-national-hybrid-conference",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-19T18:02:43.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/kane-to-showcase-revyve-at-wounds-canada-national-hybrid-conference"
  },
  "original_language": "en",
  "account": null,
  "summary": "Engaging Canadian wound-care professionals, presenting data and discussing biofilm management in clinical practice WINNIPEG, Manitoba, Oct. 19, 2026 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”), a biotechnology company commercializing and developing technologies and products that address microbial biofilms, today announced that it will attend the…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}